Guttman-McCabe Christopher 4
4 · Anterix Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Anterix Inc.ATEX
Guttman-McCabe Christopher
Chief Reg & Comm Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-28+60,000→ 60,000 totalExercise: $37.42Exp: 2034-02-28→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026.